Outlook Therapeutics is trading at $0.52, up +5.52%, with biotech sector strength potentially contributing; XBI rose 2.10% during the regular session.
- No fresh company-specific announcement explaining the October 20 move was identified.
- The company’s investor-relations page lists an October 6 release among recent announcements.
- The broader major indices were mixed in the supplied market update.